EMPACT (erythema multiforme associated with phenytoin and cranial radiation therapy) syndrome

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null

Cranial radiation exposure was not associated with T2DM risk among adult survivors of childhood ALL, and stratifying by cranial radiation exposure did not modify the associations between other risk fa

Effect: null